Drugs / UFT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00152243 | Jun 1997 → Mar 2006 | gastric cancer | Taiho Pharmaceutical Co., Ltd. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UFT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00152243 ↗ |
| Route | Oral | “uracil-tegafur 360 mg per m(2) per day orally for 16 months” PMID 17948223 ↗ Dec 2007 |